4//SEC Filing
Pearce Tillman 4
Accession 0001181431-12-010059
CIK 0001183765other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:46 PM ET
Size
5.2 KB
Accession
0001181431-12-010059
Insider Transaction Report
Form 4
Pearce Tillman
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2012-02-16−250,000→ 250,000 totalExercise: $3.46Exp: 2022-02-16→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the Option shall vest and become exercisable on February 16, 2013. Thereafter the remaining shares will vest and become exercisable at a rate of 1/36th per month.
Documents
Issuer
THRESHOLD PHARMACEUTICALS INC
CIK 0001183765
Entity typeother
Related Parties
1- filerCIK 0001542778
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 6:46 PM ET
- Size
- 5.2 KB